VA
NHC icon

Vident Advisory’s National Healthcare NHC Stock Holding History

Vident Advisory’s Portfolio NHC Stock Details NHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.46M Buy
15,408
+167
+1% +$25.6K 0.02% 561
2025
Q4 		$2.09M Sell
15,241
-2,418
-14% -$312K 0.02% 568
2025
Q3 		$2.15M Sell
17,659
-858
-5% -$92.6K 0.02% 559
2025
Q2 		$1.98M Buy
18,517
+20
+0.1% +$2K 0.02% 502
2025
Q1 		$1.72M Sell
18,497
-758
-4% -$73.4K 0.03% 530
2024
Q4 		$2.07M Sell
19,255
-9,233
-32% -$1.12M 0.04% 409
2024
Q3 		$3.58M Buy
28,488
+1,596
+6% +$201K 0.09% 228
2024
Q2 		$2.92M Buy
26,892
+948
+4% +$92.4K 0.08% 264
2024
Q1 		$2.45M Buy
25,944
+1,306
+5% +$124K 0.05% 336
2023
Q4 		$2.28M Buy
24,638
+9,701
+65% +$743K 0.06% 346
2023
Q3 		$956K Buy
+14,937
New +$957K 0.03% 524

Other funds holding NHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MSIIA
Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.04B AUM 22.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vident Advisory's NHC Position: Q1 2026 in Review

Vident Advisory increased its National Healthcare (NHC) stake by 1.1% in Q1 2026, buying an estimated $25.6K and bringing the position to 15,408 shares worth $2.46M. The position accounts for 0.02% of the portfolio, ranked #561.

Vident Advisory first reported a position in NHC in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.58M in Q3 2024. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • Vident Advisory held 15,408 shares of National Healthcare worth $2.46M as of Q1 2026.
  • Vident Advisory bought 167 National Healthcare shares in Q1 2026, an estimated $25.6K.
  • National Healthcare made up 0.02% of Vident Advisory's portfolio in Q1 2026, its #561 holding.
  • Vident Advisory first reported a position in National Healthcare in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's National Healthcare position peaked at $3.58M in Q3 2024.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.